Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05939440 · ClinicalTrials.gov registry record · NA

Interventions to Decrease Financial Toxicity

A NA study of Cervical Cancer and Uterine Cancer, sponsored by University of Alabama at Birmingham.

Completed
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT05939440 is a NA study of Cervical Cancer and Uterine Cancer that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 60 participants, below the 570-participant average among 144 other Cervical Cancer trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05939440, a NA study of Cervical Cancer and Uterine Cancer, has completed, sponsored by University of Alabama at Birmingham.

COMPLETED
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

Financial distress affects 30-70% of cancer patients and describes the burden that patients experience due to the costs of care (CoC). One reason may be because patients lack the appropriate information on CoC that would help them better plan for and manage their CoC. Therefore, the investigators plan to test a Proactive CoC intervention which includes a discussion with a trained educator on CoC information and a Cost Tracking tool to help patients deal with their CoC.

Interventions

  • OTHER Usual Care
  • OTHER Proactive Cost of Care (P-COC) intervention

Study Locations (1)

Alabama

  • O'Neal Comprehensive Cancer Center - Birmingham

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2022-06-01
Est. Completion 2025-05-31
Phase NA

Sponsor

University of Alabama at Birmingham

1,160 total trials

What the Registry Record Tells You About NCT05939440

The ClinicalTrials.gov registry entry for NCT05939440 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 570-participant average among 144 other Cervical Cancer trials with a reported enrollment target (89% lower). The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.

The record links to 6 conditions, with Cervical Cancer appearing as the primary indexed condition, and to 2 interventions - of which Usual Care is the first listed.

NCT05939440 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.

Frequently Asked Questions

What is clinical trial NCT05939440 about?

NCT05939440 is a clinical study titled "Interventions to Decrease Financial Toxicity". Financial distress affects 30-70% of cancer patients and describes the burden that patients experience due to the costs of care (CoC). One reason may be because patients lack the appropriate information on CoC that would help them better plan for and manage their CoC. Therefore, the investigators pl...

What is the current status of trial NCT05939440?

This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2022-06-01. Estimated completion is 2025-05-31.

What conditions does trial NCT05939440 study?

This clinical trial studies the following conditions: Cervical Cancer, Uterine Cancer, Vulvar Cancer, Cancer, Breast, Cancer - Ovarian.

What interventions are being tested in trial NCT05939440?

The interventions under investigation include: Usual Care (OTHER), Proactive Cost of Care (P-COC) intervention (OTHER).

Who is sponsoring clinical trial NCT05939440?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05939440 being conducted?

This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cervical Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.